Now is the time for ambition. Now is the time for inspiration. Now is the time for decisive action to create an HPV-cancer-free future for men and women across Europe. This report has been written with the input and endorsement of a wide range of organisations and individual experts with an interest in cancer and HPV. It is a multi-disciplinary and inter-professional initiative that constitutes a public appeal to decision-makers across Europe to seize the moment. The new World Health Organization (WHO) strategy for the global elimination of cervical cancer as a public health problem, together with the forthcoming Europe’s Beating Cancer Plan, the EU Cancer Mission and the EU4Health Programme, create a unique opportunity for Europe to be a...
Vaccines against human papillomavirus (HPV) are available in Europe since 2006. They have been highl...
Funding Information: M.A. was supported by the European Society of Gynaecological Oncology; the Hori...
IPVS is releasing a Call to Action to health authorities to adhere to international standards develo...
The 690,000 cases of cancer caused worldwide each year by HPV (human papillomavirus) are among the e...
The age-standardised incidence of cervical cancer in Europe varies widely by country (between 3 and ...
HPV causes about 5% of all cancers worldwide. The most common of these cancers is cervical but the v...
HPV causes about 5% of all cancers worldwide. The most common of these cancers is cervical but the v...
HPV causes about 5% of all cancers worldwide. The most common of these cancers is cervical but the v...
The age-standardised incidence of cervical cancer in Europe varies widely by country (between 3 and ...
The age-standardised incidence of cervical cancer in Europe varies widely by country (between 3 and ...
The age-standardised incidence of cervical cancer in Europe varies widely by country (between 3 and ...
The age‐standardised incidence of cervical cancer in Europe varies widely (between 3 and 25/100000 w...
The discovery that the human papillomavirus (HPV) is the necessary cause of cervical cancer has led ...
Vaccines against human papillomavirus (HPV) are available in Europe since 2006. They have been highl...
<p>The EUROGIN 2011 roadmap reviews the current burden of human papillomavirus (HPV)-related m...
Vaccines against human papillomavirus (HPV) are available in Europe since 2006. They have been highl...
Funding Information: M.A. was supported by the European Society of Gynaecological Oncology; the Hori...
IPVS is releasing a Call to Action to health authorities to adhere to international standards develo...
The 690,000 cases of cancer caused worldwide each year by HPV (human papillomavirus) are among the e...
The age-standardised incidence of cervical cancer in Europe varies widely by country (between 3 and ...
HPV causes about 5% of all cancers worldwide. The most common of these cancers is cervical but the v...
HPV causes about 5% of all cancers worldwide. The most common of these cancers is cervical but the v...
HPV causes about 5% of all cancers worldwide. The most common of these cancers is cervical but the v...
The age-standardised incidence of cervical cancer in Europe varies widely by country (between 3 and ...
The age-standardised incidence of cervical cancer in Europe varies widely by country (between 3 and ...
The age-standardised incidence of cervical cancer in Europe varies widely by country (between 3 and ...
The age‐standardised incidence of cervical cancer in Europe varies widely (between 3 and 25/100000 w...
The discovery that the human papillomavirus (HPV) is the necessary cause of cervical cancer has led ...
Vaccines against human papillomavirus (HPV) are available in Europe since 2006. They have been highl...
<p>The EUROGIN 2011 roadmap reviews the current burden of human papillomavirus (HPV)-related m...
Vaccines against human papillomavirus (HPV) are available in Europe since 2006. They have been highl...
Funding Information: M.A. was supported by the European Society of Gynaecological Oncology; the Hori...
IPVS is releasing a Call to Action to health authorities to adhere to international standards develo...